Axsome Therapeutics (AXSM) Payables (2015 - 2026)
Axsome Therapeutics' Payables was $299.63 million in Q2 2026, up 75.3% from $170.9 million a year earlier and up 19.5% from the prior quarter.
Analysis
Axsome Therapeutics (AXSM) Payables (2015 - 2026) Analysis & Trends
At the end of FY2025, Payables at Axsome Therapeutics came in at $232.85 million, up 57.3% from FY2024.
- Payables has now increased for four consecutive years, with a five-year compound annual growth rate of 76.7% (FY2020 to FY2025).
- In earlier years, Payables was $147.99 million in FY2024 (+63.5%), $90.5 million in FY2023 (+75.3%), $51.63 million in FY2022 (+292.7%) and $13.15 million in FY2021 (-2.6%).
- The Q2 2026 figure marks the highest quarterly Payables in data going back to Q4 2015.
- Compared with a year earlier, Payables has increased for 17 straight quarters, with growth averaging 66.4% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q1 2023 (growth of 366.6%); the worst was Q1 2022 (a decline of 13.9%).
- Per Business Quant data, AXSM's Payables in the three quarters before Q2 2026 was $250.73 million (Q1 2026), $232.85 million (Q4 2025) and $225.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Axsome Therapeutics | 8.09 Bn | 6.82 Bn | 204.81 Mn | 299.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 299.63 Mn |
| Mar 31, 2026 | 250.73 Mn |
| Dec 31, 2025 | 232.85 Mn |
| Sep 30, 2025 | 225.63 Mn |
| Jun 30, 2025 | 170.90 Mn |
| Mar 31, 2025 | 149.20 Mn |
| Dec 31, 2024 | 147.99 Mn |
| Sep 30, 2024 | 122.18 Mn |
| Jun 30, 2024 | 116.77 Mn |
| Mar 31, 2024 | 82.72 Mn |
| Dec 31, 2023 | 90.50 Mn |
| Sep 30, 2023 | 78.45 Mn |
| Jun 30, 2023 | 65.32 Mn |
| Mar 31, 2023 | 58.77 Mn |
| Dec 31, 2022 | 51.63 Mn |
| Sep 30, 2022 | 40.02 Mn |
| Jun 30, 2022 | 19.43 Mn |
| Mar 31, 2022 | 12.60 Mn |
| Dec 31, 2021 | 13.15 Mn |
| Sep 30, 2021 | 13.38 Mn |
API Access
Axsome Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AXSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();